33 results
8-K
EX-10.1
PTCT
PTC Therapeutics Inc
22 Sep 23
Other Events
9:00am
, as of the Closing Date, is being marketed by Borrower under the trade name Emflaza for the treatment of Duchenne muscular dystrophy.
“Environment … of the Environment or human health (to the extent related to exposure to hazardous materials), including those relating to the handling, use, manufacture
8-K
EX-99.1
PTCT
PTC Therapeutics Inc
19 Jul 23
Regulation FD Disclosure
12:00pm
. 2011; 13:697-707. 3. Hillert, et al. The American Journal of Human Genetics 2020;107,1-17. 15 PKU Presentation Both environment (dietary intake of Phe
PRE 14A
udgtqhz7ue2aavato
16 Apr 21
Preliminary proxy
4:20pm
8-K
EX-2.1
2c1g36nkj spwbnvv
6 May 20
PTC Therapeutics to Acquire Censa Pharmaceuticals
4:38pm
8-K
EX-99.1
gmu mh2pfetd8lf4v
30 Apr 20
PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
4:04pm
8-K
EX-2.1
d5vszash etymkn
30 Oct 19
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-1.1
m94yjfs90eujqe2lqo5
20 Sep 19
PTC Therapeutics Announces Pricing of Public Offering of Common Stock
4:05pm
8-K
EX-1.1
pyp0ti
7 Aug 19
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-1.1
m8oxsz
25 Jan 19
PTC Therapeutics Announces Pricing of
4:15pm